The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Medtronic's In.Pact Admiral Drug-Coated Balloon Studied in Complex PAD Patients

April 25, 2017 -- Medtronic announced the presentation of results for its In.Pact Admiral drug-coated balloon (DCB) from two new subanalyses from the IN.PACT Gl…

Twelve-Month Data Presented for Boston Scientific's Ranger DCB in Femoropopliteal Arteries

April 25, 2017 -- Boston Scientific Corporation announced results from the RANGER-SFA trial at the 2017 Charing Cross Symposium in London United Kingdom. The trial i…

Gore's Tigris Vascular Stent Evaluated in Multicenter French Experience

April 20, 2017 -- A study of a multicenter experience with the Tigris vascular stent (Gore & Associates) in France concluded that the device demonstrates continued good re…

A Tale of Two Legs: Putting Patients Ahead by Leaving Nothing Behind

Gregory A. Stanley, MD

April 2017—With the widespread use of various endovascular technologies for lower extremity revascularization, it is only appropriate that interventionists have a fundamental understandi…

An Interview With Antonio Micari, MD, PhD

April 2017—Dr. Micari discusses his protocols in Italy for treating femoropopliteal ISR, the use of bioresorbable scaffolds below the knee, and the next generation of devices in these disease settings.

Ra Medical Systems' DABRA Atherectomy System Launched in Northern Europe

April 12, 2017 -- Ra Medical Systems, a maker of excimer lasers and catheters for cardiovascular diseases as well as dermatological diseases, and Bo Medical Technologies, a mu…

Temporal Trends in Peripheral Artery Interventions Analyzed in BMC2 PVI Registry

April 6, 2017 -- Findings from a study that aimed to examine trends in procedural indications, arterial beds treated, and device usage in peripheral artery interventions were …

Enrollment Begins in DISRUPT PAD III Study of Shockwave Medical's Lithoplasty Technology

April 5, 2017 -- PinnacleHealth Cardiovascular Institute in Harrisburg, Pennsylvania, announced that the first patient in the United States was enrolled in the DISRUPT PAD III…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.